Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631, a Children's Oncology Group Study

Patrick A. Brown, MD, John Kairalla, Joanne M. Hilden, MD, Zoann Eckert Dreyer, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Cindy Wang, MS, Meenakshi Devidas, PhD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Michael J. Borowitz, MD PhD, Donald Small, MD PhD

Blood (2019) 134 (Supplement_1): 1293.

https://doi.org/10.1182/blood-2019-130564

Published: 2019

Journal Articles

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

Wanda L. Salzer, MD, Michael J. Burke, MD, Meenakshi Devidas, PhD, Lia Gore, MD, Joanne M. Hilden, MD, Eric Larsen, MD, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MD PhD, Michael J. Borowitz, MD PhD, Brent Wood, MD PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Naomi Winick, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2018) 132 (Supplement 1): 35.

https://doi.org/10.1182/blood-2018-99-116180

Published: 2018

Journal Articles

Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders

Holly Pacenta, MD, Rebecca Coughlin, Shelby Winzent, PA, Joanne M. Hilden, MD, Dianne Thornhill, PhD, Brian R. Branchford, MD, Kelly Maloney, MD, Nuechterlein Brandon, PA, Amy Keating, MD, Taizo Allen Nakano, MD, Roger Giller, MD, Christopher Michael McKinney, MD

Blood (2017) 130 (Supplement 1): 2099.

https://doi.org/10.1182/blood.V130.Suppl_1.2099.2099

Published: 2017

Journal Articles

Incidence of Allergic Reactions to Pegaspargase (PEG) Administered Intramuscularly Versus Intravenously (IM vs. IV) in Children and Young Adults with High Risk B-Lymphoblastic Leukemia (HR B-ALL): Results of Children's Oncology Group (COG) Studies AALL0232/AALL1131

Wanda Salzer, MD, Michael J. Burke, MD, Eric C. Larsen, MD, Si Chen, MS, Lia Gore, MD, Joanne M. Hilden, MD, Mignon L. Loh, MD, Elizabeth Raetz, MD, Naomi J. Winick, MD, William L. Carroll, MD, Meenakshi Devidas, PhD, Stephen P Hunger, MD

Blood (2015) 126 (23): 1303.

https://doi.org/10.1182/blood.V126.23.1303.1303

Published: 2015

Journal Articles

Use of Institutional Clinical Care Guidelines to Determine HA-VTE Risk Level for Consideration of Thromboprophylaxis in Hospitalized Children

Natalie Laing Smith, BS, Kelsey Fowlkes, BS, Beth Boulden Warren, MD MS, Beth Wathen, MSN, PNP, CCRN, Bryce Clark, RN, MPA, CPHQ, Joanne M. Hilden, MD, Daniel Hyman, MD MMM, Marilyn J. Manco-Johnson, MD, Brian R. Branchford, MD

Blood (2015) 126 (23): 3276.

https://doi.org/10.1182/blood.V126.23.3276.3276

Published: 2015

Journal Articles

Genetic Susceptibility Loci and Risk of Infant Leukemia by Subtype and MLL status: A Children's Oncology Group Report

Julie A. Ross, PhD, Amy M. Linabery, PhD, Crystal Blommer, BS, Erica Langer, BS, Logan G. Spector, PhD, Joanne M. Hilden, MD, Nyla A. Heerema, PhD, Richard L. Tower, II, MD, MS, Stella M. Davies, MBBS, PhD

Blood (2011) 118 (21): 749.

https://doi.org/10.1182/blood.V118.21.749.749

Published: 2011

Journal Articles

MLL Rearrangement and Age At Diagnosis Are Strongly Associated with High Level Surface FLT3 Expression and Ex Vivo Sensitivity to FLT3 Inhibition: A Prospective Analysis of 54 Consecutive Infants with ALL Enrolled in Children's Oncology Group (COG) Trial AALL0631

Allison J. Kaeding, Daniel Magoon, Yarden Fraiman, Tamekia Jones, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Kathleen W. Rao, PhD, Joanne M. Hilden, MD, Stephen P. Hunger, MD, Donald Small, MD, PhD, Patrick A. Brown, MD

Blood (2011) 118 (21): 568.

https://doi.org/10.1182/blood.V118.21.568.568

Published: 2011

Journal Articles

Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL - ENL , and gene Expression Profiles Determine Obatoclax IC 50 : A Report on the Children's Oncology Group (COG) P9407 Trial

Blood (2010) 116 (21): 2757.

https://doi.org/10.1182/blood.V116.21.2757.2757

Published: 2010

Journal Articles

Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study

Blood (2010) 116 (21): 412.

https://doi.org/10.1182/blood.V116.21.412.412

Published: 2010

Journal Articles

End-of-Life Experience of Children Undergoing Stem Cell Transplantation: Parent and Provider Perspectives and Patterns of Care.

Christina K Ullrich, MD, MPH, Veronica Dussel, MD, MPH, Joanne M. Hilden, MD, Jan W. Sheaffer, BA, Leslie E. Lehmann, MD, Joanne Wolfe, MD, MPH

Blood (2009) 114 (22): 805.

https://doi.org/10.1182/blood.V114.22.805.805

Published: 2009

Journal Articles

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Blaine W. Robinson, PhD, Meenakshi Devidas, PhD, Andrew J. Carroll, PhD, Richard C. Harvey, PhD, Nyla A. Heerema, PhD, Cheryl L. Willman, MD, Amanda R. Hudome, Elliot C. Woods, Nancy C. Ballantyne, Gregory H. Reaman, MD, Joanne M. Hilden, MD, Bruce M. Camitta, MD, Naomi J. Winick, MD, William L. Carroll, MD, Stephen P Hunger, MD, Zoann E. Dreyer, MD, Carolyn A. Felix, MD

Blood (2009) 114 (22): 907.

https://doi.org/10.1182/blood.V114.22.907.907

Published: 2009

Journal Articles

Report On Excessive Induction Toxicity in Infants with ALL Enrolled On COG Protocol AALL0631: A Children's Oncology Group Study.

Patrick Brown, MD, Joanne M. Hilden, MD, Zoann E. Dreyer, MD, Naomi J. Winick, MD, Wanda Salzer, MD, Elizabeth Raetz, MD, Lillian Sung, MD, Theoklis E Zaoutis, MD, MSCE, Tamekia Jones, PhD, Meenakshi Devidas, PhD, Paola De Lorenzo, Maria Grazia Valsecchi, PhD, Rob Pieters, William L. Carroll, MD, Stephen P Hunger, MD

Blood (2009) 114 (22): 3091.

https://doi.org/10.1182/blood.V114.22.3091.3091

Published: 2009

Journal Articles

Age Is the Strongest Determinant of Leukemia Blast Cell Gene Expression in MLL -Rearranged Infant ALL and MLL-AF4 Directs a Distinct Gene Expression Profile Related to CNS Disease.

Blaine W. Robinson, PhD, Kajia Cao, PhD, Joanne M. Hilden, MD, Patricia A. Dinndorf, MD, Nyla A. Heerema, PhD, Harland N. Sather, Ron McGlennen, Stephen P. Hunger, MD, Gregory H. Reaman, MD, Li-San Wang, PhD, Carolyn A. Felix, MD

Blood (2008) 112 (11): 1200.

https://doi.org/10.1182/blood.V112.11.1200.1200

Published: 2008

Journal Articles

Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group (COG) Study A2971.

Mukta Sharma, MD, Todd A. Alonzo, PhD, April Sorrell, MD, Robert B. Gerbing, MA, Joanne M. Hilden, MD, Robert J. Arceci, MD, PhD, Gita Massey, MD, John J. Doyle, MD, Lisa Bayer, CPNP, John P. Perentesis, MD, Julie Ross, PhD, Franklin O. Smith, MD, Russell Brynes, MD, Jerry Hussong, MD, Lois Hathaway, Alan Gamis, MD

Blood (2006) 108 (11): 376.

https://doi.org/10.1182/blood.V108.11.376.376

Published: 2006

Journal Articles

Chemotherapy-Related Amenorrhea (CRA) among Premenopausal Patients Treated for Acute Leukemia.

Suzanne R. Fanning, DO, Tao Jin, MS, Joanne M. Hilden, MD, Anjali Advani, MD, Matt Kalaycio, MD, Alan E. Lichtin, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Halle C.F. Moore, MD

Blood (2006) 108 (11): 3315.

https://doi.org/10.1182/blood.V108.11.3315.3315

Published: 2006

Journal Articles

The Racial Disparity Gap in Pediatric Leukemia and Lymphoma Survival Has Been Eliminated in Children but Not in Older Adolescents and Young Adults.

Aaron Viny, BS, Joanne M. Hilden, MD, Anthony Stallion, MD, W. Archie Bleyer, MD

Blood (2006) 108 (11): 76.

https://doi.org/10.1182/blood.V108.11.76.76

Published: 2006

Journal Articles

Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial - Initial Report of the COG Trial A2971.

Alan S. Gamis, MD, Todd A. Alonzo, PhD, Joanne M. Hilden, MD, Robert B. Gerbing, MA, Thomas W. Loew, MD, Lois Hathaway, CCRP, Loris McGavran, PhD, Dorothy Barnard, MD, Jeffrey W. Taub, MD, Yaddanapudi Ravindranath, MD, Franklin O. Smith, MD, Robert Arceci, MD, PhD

Blood (2006) 108 (11): 15.

https://doi.org/10.1182/blood.V108.11.15.15

Published: 2006

Journal Articles

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

Joanne M. Hilden, MD, Patricia A. Dinndorf, MD, Sharon O. Meerbaum, Harland Sather, PhD, Doojduen Villaluna, PhD, Nyla A. Heerema, PhD, Ron McGlennen, MD, Franklin O. Smith, MD, William G. Woods, MD, Zoann Dryer, MD, Gregory H. Reaman, MD

Blood (2005) 106 (11): 7.

https://doi.org/10.1182/blood.V106.11.7.7

Published: 2005

NARROW

FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631, a Children's Oncology Group Study

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders

Incidence of Allergic Reactions to Pegaspargase (PEG) Administered Intramuscularly Versus Intravenously (IM vs. IV) in Children and Young Adults with High Risk B-Lymphoblastic Leukemia (HR B-ALL): Results of Children's Oncology Group (COG) Studies AALL0232/AALL1131

Use of Institutional Clinical Care Guidelines to Determine HA-VTE Risk Level for Consideration of Thromboprophylaxis in Hospitalized Children

Genetic Susceptibility Loci and Risk of Infant Leukemia by Subtype and MLL status: A Children's Oncology Group Report

MLL Rearrangement and Age At Diagnosis Are Strongly Associated with High Level Surface FLT3 Expression and Ex Vivo Sensitivity to FLT3 Inhibition: A Prospective Analysis of 54 Consecutive Infants with ALL Enrolled in Children's Oncology Group (COG) Trial AALL0631

Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL - ENL , and gene Expression Profiles Determine Obatoclax IC 50 : A Report on the Children's Oncology Group (COG) P9407 Trial

Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study

End-of-Life Experience of Children Undergoing Stem Cell Transplantation: Parent and Provider Perspectives and Patterns of Care.

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Report On Excessive Induction Toxicity in Infants with ALL Enrolled On COG Protocol AALL0631: A Children's Oncology Group Study.

Age Is the Strongest Determinant of Leukemia Blast Cell Gene Expression in MLL -Rearranged Infant ALL and MLL-AF4 Directs a Distinct Gene Expression Profile Related to CNS Disease.

Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group (COG) Study A2971.

Chemotherapy-Related Amenorrhea (CRA) among Premenopausal Patients Treated for Acute Leukemia.

The Racial Disparity Gap in Pediatric Leukemia and Lymphoma Survival Has Been Eliminated in Children but Not in Older Adolescents and Young Adults.

Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial - Initial Report of the COG Trial A2971.

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only